REG - Crystal Amber Fund - Cancellation of treasury shares

Crystal Amber FundAnnouncement

12/01/2026 18:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260112:nRSL5903Oa&default-theme=true

RNS Number : 5903O  Crystal Amber Fund Limited  12 January 2026

 

 

12 January 2026

 

Crystal Amber Fund Limited

("Crystal Amber Fund", the "Company" or the "Fund")

 

Cancellation of Treasury Shares

 

The Company announces that on 9 January 2026, 7,546,500 of the Company's
ordinary shares of 1 penny each ("Ordinary Shares") were cancelled. These
Ordinary shares were previously held in treasury and represent Ordinary shares
bought back by the Company from 27 March 2025 to 23 December 2025.

 

Following the above cancellation, Crystal Amber holds 16,708,762 Ordinary
Shares in treasury and the number of shares in issue and total voting rights
in the Company are as follows:

 

                  Number of shares in issue  Number of voting rights
 Ordinary Shares  77,077,262                 60,368,500

 

 

 

The voting rights figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, the Company under
the Disclosure Guidance and Transparency Rules.

 

For further enquiries please contact:

 

Crystal Amber Fund Limited

Chris Waldron (Chairman)

Tel: 01481 742 742

www.crystalamber.com (http://www.crystalamber.com)

 

Allenby Capital Limited - Nominated Adviser

Jeremy Porter/ Ashur Joseph

Tel: 020 3328 5656

 

Winterflood Investment Trusts - Broker

Joe Winkley/Neil Langford

Tel: 020 3100 0160

 

Crystal Amber Advisers (UK) LLP - Investment Adviser

Richard Bernstein

Tel: 020 7478 9080

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCEAXFAFLDKEFA



            Copyright 2019 Regulatory News Service, all rights reserved